Oncology

Resource Center

Commentary

Research Summaries

Conference Coverage

Conference Coverage

Video Recap—Multiple Myeloma Across the Care Continuum

08/13/2026

Brittany Watson, MD, MPH; Joseph Mikhael, MD, MEd, FRCPC

In this video, Brittany Watson, MD, MPH, FAAFP, DABOM and Joseph Mikhael, MD, MEd, FRCPC, FACP, discuss the role of primary care in the early recognition and diagnosis of multiple myeloma, including the...

08/13/2026

Research Summary

Research Summary

UK Biobank and Preclinical Study Links Obesity to Myeloid Leukemia, Identifies Dual GLP-1R/IL-17A Strategy

08/11/2026

Anthony Calabro, MA

An integrated UK Biobank and preclinical study linked obesity-related metabolic inflammation to PTPN11-mutant myeloid leukemia and found that combined GLP-1R agonism and IL-17A blockade reduced leukemic...

08/11/2026

Research Summary

Research Summary

COMPASS AI Model Predicts Immunotherapy Response

08/07/2026

Anthony Calabro, MA

A pan-cancer modeling study found that COMPASS predicted immune checkpoint inhibitor response across 16 clinical cohorts and achieved higher average accuracy and area under the precision-recall curve than...

08/07/2026

RESEARCH SUMMARY

RESEARCH SUMMARY

Ibrutinib Plus R-da-EPOCH Shows Manageable Toxicity in HIV-Related DLBCL

07/31/2026

Anthony Calabro, MA

In a multicenter dose de-escalation and expansion study of adults with HIV-related DLBCL, ibrutinib plus R-da-EPOCH showed manageable toxicity and clinical activity, with 3-year event-free and overall...

07/31/2026

FDA Alert

FDA Alert

FDA Approves Keytruda-Based Regimens for Muscle-Invasive Bladder Cancer

07/28/2026

Ashton L. Stahl

FDA expanded perioperative pembrolizumab-based treatment options for adults with muscle-invasive bladder cancer.

07/28/2026

August 2026

Current Issue

August 2026